Emeis share breaks below its 11.94 € support level and extends its decline
The medicalised accommodation and care group is losing ground this Thursday afternoon, crossing downward a technical threshold monitored over several sessions. The momentum remains deteriorated across all short-term horizons, in a European market itself slightly in the red.
An 11.94 € support broken during the session, within a persistent downtrend context
The Emeis share is declining by 2.74% to 11.72 € during this Thursday's session, after breaking through its 11.94 € support level downward. The stock remains below this threshold, confirming the fragility of the chart configuration. Over one month, the decline reaches 16.17%, and over one week, the stock is down a further 5.48%, making it one of the steepest declines of this period.
Three moving averages are weighing well above the price: the 20-day MA at 12.60 € (a gap of nearly 7%), the 50-day MA at 13.49 € (a gap of more than 13%) and the 200-day MA at 13.98 € (a gap of more than 16%), with the stock trading below all three levels. The RSI at 33 is approaching the oversold zone without yet reaching it outright, reflecting the progressive exhaustion of selling pressure at these levels. The nearest resistance, at 14.45 €, remains very far from the current price.
First-half results revised upward but a stock market dynamic that is not following suit
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Upon publication of the first half of 2026 (on July 29, 2026), the group had raised its annual guidance, indicating that first-half performance "allowed for an upward revision of 2026 objectives" and even showed "results exceeding initial expectations". This confident tone contrasts with the stock decline accumulated since last summer. The stock had touched a low point at 11.78 € on September 21, before a rebound that failed to hold in the following sessions.
In a difficult market context for risk assets, the SBF 120 is down 0.26% during the session, as rising bond yields weigh on stock valuations across Europe. The next technical landmark to watch remains the lower boundary around 11.78 €, already tested last week.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2026
Key reported figures
Revenue: 4 543 millions d'euros
Quarterly revenue: 4 543 millions d'euros
Revenue growth: 3,5 %
Guidance from the release
« Les tendances observées lors des 9 premiers mois de l'année 2026 confortent emeis dans l'atteinte des objectifs pour 2026, objectifs par ailleurs relevés fin juillet. »
Risks mentioned
Health crises linked to flu outbreaks and heat waves requiring proactive management
Macroeconomic uncertainty and risk of return to inflation impacting operating expenses
Dependency on continued execution of operational efficiency programs such as the Boost initiative in France
Opportunities identified
Strong like-for-like revenue growth of +6.0% driven by improved occupancy rates and favorable pricing effects
Average occupancy rate now above 90% with +2.9 pts annual increase, particularly strong in nursing homes (+3.1 pts)
Structural demographic tailwind with European senior population aged 85+ expected to grow over 30% in next 10 years
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.